Development
DexCom, Inc.
DXCM
$82.26
$1.642.03%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | 541.50M | 377.00M | 357.50M | 292.50M | 341.20M |
Total Depreciation and Amortization | 202.50M | 186.20M | 177.20M | 177.10M | 172.30M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.30M | -11.10M | 66.00M | 108.60M | 129.30M |
Change in Net Operating Assets | 3.20M | 195.30M | 170.70M | 175.70M | 26.70M |
Cash from Operations | 748.50M | 747.40M | 771.40M | 753.90M | 669.50M |
Capital Expenditure | -236.60M | -247.60M | -305.40M | -337.90M | -364.80M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | 0.00 | -700.00K | -700.00K | -3.90M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -270.60M | -868.60M | -401.30M | 42.20M | -152.80M |
Cash from Investing | -507.20M | -1.12B | -707.40M | -296.40M | -521.50M |
Total Debt Issued | 1.23B | 1.23B | 1.23B | -- | -- |
Total Debt Repaid | -787.30M | -650.50M | -- | -- | -- |
Issuance of Common Stock | 26.60M | 26.60M | 24.70M | 24.70M | 22.50M |
Repurchase of Common Stock | -688.70M | -188.70M | -746.40M | -557.70M | -557.70M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -99.80M | -105.70M | -111.70M | -13.60M | -17.30M |
Cash from Financing | -318.60M | 312.30M | 397.20M | -546.60M | -552.50M |
Foreign Exchange rate Adjustments | 1.50M | 2.20M | -1.60M | -3.70M | -5.80M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -75.80M | -54.30M | 459.60M | -92.80M | -410.30M |